Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-123185

SVP, Chief Business Officer sold 27,500 shares at $4.89 ($134,475)

  • SVP, Chief Business Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan SVP, Chief Business Officer 2021-10-01 Option exercise +27,500 $0.92 $25,300 44,667 D: show line 1 in the form
Korbel Gregory Alan SVP, Chief Business Officer 2021-10-01 Sale −27,500 $4.89 $134,475 17,167 D: show line 2 in the form
Open-market sales · 27,500 sh · avg $4.89 · $134,475

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Korbel Gregory Alan SVP, Chief Business Officer 2021-10-01 Option exercise · Stock Option (right to Buy) −27,500 25,245 D: show line 3 in the form
Loading xslF345X03/tm2129205-1_4seq1.xml…